Literature DB >> 12417403

Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy.

Prabhjit K Grewal1, Jane E Hewitt.   

Abstract

The myodystrophy (myd) mutation arose spontaneously and has an autosomal recessive mode of inheritance. Homozygous mutant mice display a severe, progressive muscular dystrophy. Using a positional cloning approach, we identified the causative mutation in myd as a deletion within the Large gene, which encodes a putative glycosyltransferase with two predicted catalytic domains. By immunoblotting, the alpha-subunit of dystroglycan, a key muscle membrane protein, is abnormal in myd mice. This aberrant protein might represent altered glycosylation of the protein and contribute to the muscular dystrophy phenotype. Our results are discussed in the light of recent reports describing mutations in other glycosyltransferase genes in several forms of human muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417403     DOI: 10.1016/s0304-4165(02)00387-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies.

Authors:  P C G Onofre-Oliveira; A L F Santos; P M Martins; D Ayub-Guerrieri; M Vainzof
Journal:  Neuromolecular Med       Date:  2012-02-24       Impact factor: 3.843

Review 3.  The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.

Authors:  Lance Wells
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

4.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

Review 5.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

Review 7.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

8.  The attachment disorders of muscle: failure to carb-load.

Authors:  Elizabeth M McNally
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

9.  Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different?

Authors:  Camila F Almeida; Poliana Cm Martins; Mariz Vainzof
Journal:  Eur J Hum Genet       Date:  2016-03-02       Impact factor: 4.246

10.  Mutational and functional analysis of Large in a novel CHO glycosylation mutant.

Authors:  Jennifer T Aguilan; Subha Sundaram; Edward Nieves; Pamela Stanley
Journal:  Glycobiology       Date:  2009-05-21       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.